MATT ABERNETHY - Chief Financial Officer at NEUROCRINE BIOSCIENCES INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
NBIX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by MATT ABERNETHY since 26 Feb 2025

Holdings reported by MATT ABERNETHY for NEUROCRINE BIOSCIENCES INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 44,881 $5,570,629 $124.12 13 Feb 2026 Direct
Restricted Stock Unit 7,735 $795,399 $118.28 13 Feb 2026 Direct Common Stock
Stock Option 44,095 13 Feb 2026 Direct Common Stock

Transactions reported by MATT ABERNETHY for NEUROCRINE BIOSCIENCES INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.